[25] [26] It's worth noting that most clinical trials of GLP-1 medications excluded patients with significant active gastrointestinal disease, creating an evidence gap for those with severe or poorly controlled IBD
studies suggest people with increased glutathione levels fell asleep easier and woke up more refreshed in the morning
That might sound alarming, but its actually not that surprising
They focus on cellular health, which for me, really resonates with the idea of feeling good from the inside out
That works at first, but as titration schedules, missed doses, injection-site changes, and notes about side effects pile up, the process becomes messy: missed steps slow down tolerance, inconsistent injection sites can cause irritation, and symptom patterns get lost in notes or memory
That is why it is regarded as the newest generation in this research class